Inovio added to russell 2000® index effective july 1, 2024

Plymouth meeting, pa. , july 1, 2024 /prnewswire/ -- inovio (nasdaq: ino), a biotechnology company focused on developing and commercializing dna medicines to help treat and protect people from hpv-associated diseases, cancer and infectious diseases, today announced its inclusion in the russell 2000® index as part of the annual reconstitution of the russell stock indexes.
INO Ratings Summary
INO Quant Ranking